Metagenomi Therapeutics (MGX)
Develops genetic medicines from microbial genome-editing systems.
$1.17
At close0.00 (0.00%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions47 holders · as of Mar 31, 2026 | 17.11% | 6.46M shares | |
| Insiders5 holders · as of Jun 10, 2026 | 9.29% | 3.51M shares | |
| Otherremainder | 73.60% | 27.80M shares |
37.78M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
47 holders · 6.46M shares · 6 new positions · 14 increased · 14 reduced · 13 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 1.06M | 2.80% | +1.06Mnew | May 15, 2026 |
| Renaissance Technologies LLC | 787.9K | 2.09% | +159.5K | May 14, 2026 |
| Catalio Capital Management, LP | 529.0K | 1.40% | 0 | May 15, 2026 |
| Peapod Lane Capital LLC | 516.8K | 1.37% | +19.1K | May 4, 2026 |
| Two Sigma Investments, LP | 496.8K | 1.31% | +55.4K | May 15, 2026 |
| Bridgeway Capital Management, LLC | 395.8K | 1.05% | 0 | May 15, 2026 |
| Jacobs Levy Equity Management, Inc | 382.2K | 1.01% | +382.2K | May 15, 2026 |
| Geode Capital Management, LLC | 358.2K | 0.95% | +52.3K | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Bayer US Holding LPincl. Bayer World Investments B.V., Bayer Aktiengesellschaft +1 more | 10.80% | 4.05M | 13G | Nov 6, 2024 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 5, 2026 | Matthew Weinofficer: See Remarks | Sale | 558 | $1.30 | 126,491 |
| Jun 5, 2026 | Jian Irishdirector, officer: See Remarks | Sale | 3,737 | $1.30 | 377,533 |
| Jun 5, 2026 | Pamela Wapnickofficer: Chief Financial Officer | Sale | 2,884 | $1.30 | 208,491 |
| Mar 5, 2026 | Jian Irishdirector, officer: Chief Executive Officer | Sale | 1,607 | $1.60 | 333,770 |
| Mar 5, 2026 | Matthew Weinofficer: See Remarks | Sale | 482 | $1.60 | 114,549 |
| Mar 5, 2026 | Pamela Wapnickofficer: Chief Financial Officer | Sale | 1,581 | $1.60 | 187,375 |
| Dec 5, 2025 | Jian Irishdirector, officer: Chief Executive Officer | Sale | 1,602 | $1.77 | 563,839 |
| Dec 5, 2025 | Pamela Wapnickofficer: Chief Financial Officer | Sale | 1,576 | $1.77 | 188,956 |
| Dec 5, 2025 | Matthew Weinofficer: See Remarks | Sale | 199 | $1.77 | 115,031 |
| Dec 5, 2025 | Brian C. Thomasdirector | Sale | 3,830 | $1.77 | 2,510,960 |
CongressHouse and Senate disclosures
Not reported.